A 12-week international, multicenter, open label, non-comparative study to evaulate the feasibility of switching any antipsychotic treatment to sustained-release quetiapine fumarate (Seroquel) in patients with schizophrenia
Phase of Trial: Phase III
Latest Information Update: 03 Jan 2013
At a glance
- Drugs Quetiapine (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 29 Apr 2009 Cost-utility analysis based on this study published in Current Medical Research and Opinion, Mar, 2009.
- 31 Dec 2005 New trial record.